✦ LIBER ✦

Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial

✍ Scribed by Eberhardt, W; Stamatis, G; Stuschke, M; Wilke, H; Müller, M R; Kolks, S; Flasshove, M; Schütte, J; Stahl, M; Schlenger, L

Book ID: 110002610
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 80 KB
Volume: 81
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6690830

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

86 Preliminary results of a stage orient

86 Preliminary results of a stage oriented multimodality treatment including surgery for selected subgroups of limited disease small cell lung cancer (SCLC)

✍ W. Eberhardt; H. Wilke; G. Stamatis; S. Kolks; M. Stuschke; M.R. Müller; L. Schl 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

P-210 Preliminary results (SLCG 9901 pha

P-210 Preliminary results (SLCG 9901 phase II trial) of neoadjuvant chemotherapy followed by surgery in selected stage IIIB non-small-cell lung cancer (NSCLC) patients (p)

✍ Muguruza, Ignacio; Gomez, A.; Tarrazona, Vicente; Madrigal, Luis; Aguilo, Rafael 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Long term results of a phase I/II study

Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer

✍ James A. Bonner; Robert T. Eagan; Vichaivood Liengswangwong; Stephen Frytak; Edw 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Background. A Phase 1/11 study of an aggressive sixdrug chemotherapy regimen followed by the use of sequential hemibody radiation therapy as a possible noncross-resistant systemic treatment was undertaken for patients with extensive stage small cell lung cancer. Methods. The 20 enrolled patients re

143P CISPLATINUM PLUS DOCETAXEL (CD) AS

143P CISPLATINUM PLUS DOCETAXEL (CD) AS INDUCTION CHEMOTHERAPY PRIOR TO RADICAL LOCOREGIONAL (LR) TREATMENT FOR PATIENTS (PTS) WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A PROSPECTIVE PHASE II STUDY

✍ Berros, J.P.; Esteban, E.; Crespo, G.; Muriel, C.; Sanmamed, M.F.; Pardo, P.; Iz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB